Ceesay Abraham
SEC insider (Form 3/4/5 filer). CIK 0001722140. Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP) and 2 other issuers. 50 reported Form 4/5 transactions since Sep 2024; latest on Oct 21, 2026. Located in BOSTON, MA.
Companies Ceesay Abraham has filed insider reports for
- Rapport Therapeutics, Inc. (RAPP): Director, Officer, Chief Executive Officer
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL): Director
- Pacira BioSciences, Inc. (PCRX): Director
Ceesay Abraham
CIK: 0001722140
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (50 total)
- Oct 21, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect2.2K shares at avg. $29.16$64K - Oct 7, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect1.1K shares at avg. $30.66$35K - Oct 6, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect3.4K shares at avg. $32.03$108K - Sep 23, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect215 shares at avg. $39.86$9K - Sep 23, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect43 shares at avg. $41.05$2K - Sep 23, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect2K shares at avg. $39.05$76K - Sep 8, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect1.1K shares at avg. $46.01$49K - Sep 8, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect7.1K shares at avg. $45.55$325K - Aug 25, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect18.9K shares at avg. $49.57$938K - Aug 11, 2026RAPP
Rapport Therapeutics, Inc.
SaleDirect3.7K shares at avg. $46.90$172K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 |  RAPP Rapport Therapeutics, Inc. | Sale | 2,210 | $29.16 | $64,448 | Direct |
| Oct 7, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 1,147 | $30.66 | $35,167 | Direct |
| Oct 6, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 3,375 | $32.03 | $108,106 | Direct |
| Sep 23, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 215 | $39.86 | $8,570 | Direct |
| Sep 23, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 43 | $41.05 | $1,765 | Direct |
| Sep 23, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 1,952 | $39.05 | $76,230 | Direct |
| Sep 8, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 1,069 | $46.01 | $49,190 | Direct |
| Sep 8, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 7,141 | $45.55 | $325,308 | Direct |
| Aug 25, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 18,921 | $49.57 | $937,957 | Direct |
| Aug 11, 2026 | RAPP Rapport Therapeutics, Inc. | Sale | 3,664 | $46.90 | $171,837 | Direct |
1-10 of 50 transactions